Physician profile
John Bennet
NPI 1255435798
$2,844.33
in general payments reported to CMS, 2019-2025
20 companies · $73.42 in 2025
The $73.42 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $488 · 2020: $354 · 2021: $707 · 2022: $557 · 2023: $349 · 2024: $316 · 2025: $73.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $738.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $749.67 | 2019-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $455.19 | 2019-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Corium, LLC | $377.71 | 2021-2025 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $215.92 | 2020-2022 | |
| Glaxosmithkline, LLC. | $212.98 | 2019-2024 | Bexsero |
| Tris Pharma INC | $196.16 | 2019-2023 | Dyanavel Xr |
| Pfizer INC. | $141.86 | 2019-2023 | |
| Sanofi Pasteur INC. | $112.00 | 2021-2023 | |
| Neos Therapeutics, Lp | $93.86 | 2019-2024 | Adzenys Xr-Odt |
| Cranial Technologies, INC | $58.44 | 2019-2023 | Doc Band |
| Genentech USA, INC. | $54.43 | 2020-2021 | |
| Shire North American Group INC | $40.67 | 2019 | |
| Supernus Pharmaceuticals, INC. | $29.48 | 2021-2022 | |
| Hologic Sales and Service, LLC | $17.59 | 2023 | Coolseal Generator |
| Cognoa, INC. | $16.11 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $15.43 | 2019 | |
| Sobi, INC | $15.24 | 2019 | |
| Seqirus USA INC | $14.75 | 2023 | Flucelvax Quadrivalent |
| Mission Pharmacal Company | $13.44 | 2019 | |
| Adlon Therapeutics L.P. | $13.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bennet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.